Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

16.69
-0.0500-0.30%
Volume:654.66K
Turnover:10.87M
Market Cap:1.30B
PE:-179.24
High:17.00
Open:16.74
Low:16.39
Close:16.74
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:1.14
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:1.25
PE(LYR):-2.48

Loading ...

Integra LifeSciences CFO Lea Knight presents at Jefferies Global Healthcare Conference

Reuters
·
Jun 02

Integra Lifesciences Holdings Corp : Citigroup Raises to Neutral From Sell; Raises Target Price to $16 From $11

THOMSON REUTERS
·
May 29

Integra LifeSciences Raised to Neutral From Sell by Citigroup

Dow Jones
·
May 29

Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11

MT Newswires Live
·
May 28

Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)

TIPRANKS
·
May 14

Integra LifeSciences shareholders approve equity plan amendment at annual meeting

Reuters
·
May 09

Integra LifeSciences CFO Lea Knight presents at BofA Securities health care conference

Reuters
·
May 08

Integra LifeSciences price target raised to $11 from $9 at Citi

TIPRANKS
·
May 07

Integra LifeSciences Is Maintained at Sell by Citigroup

Dow Jones
·
May 07

Integra Lifesciences (IART) Gets a Buy from Jefferies

TIPRANKS
·
May 07

Integra LifeSciences names Stuart Essig president and CEO in leadership transition

Reuters
·
May 06

Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating

MT Newswires Live
·
May 06

Truist Financial Keeps Their Hold Rating on Integra Lifesciences (IART)

TIPRANKS
·
May 06

Integra Lifesciences Earnings Call Highlights Mixed Recovery

TIPRANKS
·
May 06

Integra LifeSciences Up Nearly 30%, on Pace for Largest Percent Increase Since February 2000 -- Data Talk

Dow Jones
·
May 05

Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins

Dow Jones
·
May 05

GUIDANCE: (IART) Integra LifeSciences Holdings Expects 2026 Adjusted EPS Range $2.40 - $2.50

MT Newswires Live
·
May 05

Integra Lifesciences Q1 Adj. EPS $0.54 Beats $0.41 Estimate, Sales $391.918M Beat $381.870M Estimate

Benzinga Earnings
·
May 05

BRIEF-Integra Lifesciences Announces Leadership Transition

Reuters
·
May 05

Integra LifeSciences Q1 FY26 adjusted EPS rises 31.7% to 0.54; revenue increases 2.4% to 391.9 million

Reuters
·
May 05